This article has Open Peer Review reports available.
A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II–IIIA non-small cell lung cancer: study protocol for a randomized controlled trial
- Hideo Saka1, 17, 19Email author,
- Chiyoe Kitagawa1, 17,
- Yukito Ichinose2,
- Mitsuhiro Takenoyama2,
- Hidenori Ibata3,
- Tatsuo Kato4,
- Koji Takami5,
- Motohiro Yamashita6,
- Tadashi Maeda7,
- Sadanori Takeo8,
- Hitoshi Ueda9,
- Kan Okabayashi10,
- Seiji Nagashima11,
- Tadayuki Oka12,
- Hidenori Kouso13,
- Seiichi Fukuyama14,
- Kentaro Yoshimoto15,
- Mototsugu Shimokawa16,
- Akiko M. Saito17 and
- Suminobu Ito18
© The Author(s). 2017
Received: 12 December 2016
Accepted: 12 July 2017
Published: 15 September 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|12 Dec 2016||Submitted||Original manuscript|
|24 Apr 2017||Reviewed||Reviewer Report - Joel Dubin|
|3 Jul 2017||Author responded||Author comments - Hideo Saka|
|Resubmission - Version 2|
|3 Jul 2017||Submitted||Manuscript version 2|
|12 Jul 2017||Editorially accepted|
|15 Sep 2017||Article published||10.1186/s13063-017-2103-4|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.